Alfresa Holdings Corporation operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Alfresa Holdings with three other
companies in this sector in Japan:
Toho Holdings Company Limited
sales of 1.31 trillion Japanese Yen [US$11.62 billion]
of which 92%
was Pharmaceutical Wholesale Business),
Medipal Holdings Corporation
(3.03 trillion Japanese Yen [US$26.89 billion]
of which 70%
was Pharmaceuticals And Other Products Whole), and
Suzuken Co., Ltd.
(2.23 trillion Japanese Yen [US$19.79 billion]
of which 93%
was Pharmaceutical Wholesale Business).
During the year ended March of 2016, sales at
Alfresa Holdings were ¥2.58 trillion (US$22.88 billion).
increase of 6.4%
versus 2015, when the company's sales were ¥2.42 trillion.
Sales of Manufacturing Pharmaceuticals, Etc. saw an increase
that was more than double the company's growth rate: sales were up
32.4% in 2016, from
¥16.67 billion to ¥22.07 billion.
Alfresa Holdings also saw significant increases in sales in
Wholesale Business of Self-Medication (up 22.4% to ¥244.09 billion)